Nanomerics

Nanomerics is a speciality pharmaceutical company which was spun out from University College London. Nanomerics creates differentiated medicines based on its patented Molecular Envelope Technology (MET).

membership
Organisation type
Prof Ijeoma Uchegbu
Chief Scientific Officer 

Nascient Ltd

Nascient Ltd is a funded, privately-held biotech company developing novel therapies for the treatment of inflammatory diseases.

Based in the United Kingdom, Nascient is developing Matriximab, a fully human mAb targeting the Fibrinogen Globe (FBG) of Tenascin C. FBG is a novel therapeutic target involved in the initiation of acute inflammation and the onset of chronic disease.

Nascient is funded by Imperial Innovations.

Organisation type
Mr Douglas Thomson
Director 
Dr Eric Culbert
CSO